Companies

QuidelOrtho Corp (QDEL) SEC filings

CIK 0001906324 · In Vitro & In Vivo Diagnostic Substances (SIC 2835) · Nasdaq · fiscal year ends 01/01

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022
Revenue (USD)2.7 B3.3 B
Net income (USD)810.3 M
Diluted EPS (USD/shares)-16.699.56

Latest filings

FiledFormDescriptionPeriod
2026-10-194FORM 42026-10-15
2026-10-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-238-K8-K items 1.01,9.012026-09-23
2026-09-174FORM 42026-09-15
2026-08-184FORM 42026-08-15
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13GSCHEDULE 13G
2026-08-0710-Q10-Q2026-06-28
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-05SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-164FORM 42026-07-15
2026-07-153FORM 32026-07-06
2026-07-13S-8S-8
2026-07-08SCHEDULE 13GSCHEDULE 13G
2026-07-024FORM 42026-07-01
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25
2026-06-294FORM 42026-06-25

Forms on file (last 1,000): 4 302, 8-K 51, 3 30, SCHEDULE 13G/A 19, 10-Q 13, SC 13G/A 12, SCHEDULE 13G 8, SC 13D/A 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=QDEL (0.002 USD), /gw/filings/filings?ticker=QDEL&form=8-K, /gw/filings/facts?ticker=QDEL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange